Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-20
2005-09-20
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S531000
Reexamination Certificate
active
06946481
ABSTRACT:
A compound of the formula (I):or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
REFERENCES:
patent: 5767144 (1998-06-01), Winn et al.
patent: 6011019 (2000-01-01), Thomas et al.
patent: 6680336 (2004-01-01), Martins et al.
patent: 6716843 (2004-04-01), De Nanteuil et al.
patent: 6737436 (2004-05-01), Eggenweiler et al.
patent: 6759429 (2004-07-01), Tokunaga et al.
Boyd Steven A.
Henry Kenneth J.
Hutchins Charles W.
Jae Hwan-Soo
Kester Jeffrey A.
Abbott Laboratories
Donner B. Gregory
Lambkin Deborah C.
LandOfFree
Endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3386918